Extravascular Hemolysis

Extravascular hemolysis is a condition where red blood cells are destroyed outside of the blood vessels, mainly in the spleen and liver. This process affects the blood and immune systems because it involves the removal of damaged or old red blood cells by specialized cells called macrophages. When red blood cells break down prematurely, it can lead to symptoms like fatigue, paleness, and jaundice due to the release of bilirubin. The body tries to compensate by producing more red blood cells in the bone marrow, which may cause an enlarged spleen. This condition can result from inherited disorders, immune reactions, or infections that affect red blood cells.

Extravascular hemolysis is the destruction of red blood cells primarily by macrophages in the reticuloendothelial system, especially the spleen and liver. It occurs when red blood cells become damaged, altered, or coated with antibodies, leading to their recognition and phagocytosis by splenic macrophages. Common causes include hereditary spherocytosis, autoimmune hemolytic anemia, and certain infections. The process results in the release of unconjugated bilirubin, causing jaundice and increased erythropoietic activity in the bone marrow. Unlike intravascular hemolysis, hemoglobin is not released directly into the bloodstream, so hemoglobinemia and hemoglobinuria are typically absent. This mechanism is clinically significant because it leads to anemia, splenomegaly, and potential gallstone formation due to chronic bilirubin overload.